Abstract:Objective To evaluate the therapeutic effect and possible mechanism of PPARγ agonist rosiglitazone on 2, 4, 6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in mice. Methods Twenty male BALB/c mice were selected to establish TNBS-induced colitis model and were randomly divided into rosiglitazone treated group and model group with 10 rats in each group. Rosiglitazone group was treated with rosiglitazone(0.2 mL, [20 mg/(kg.d)])and model group with normal saline(0.2 mL/d). After 6 weeks of administration, the mice were sacrificed. Inflammatory bowel disease disease activity index (DAI) and HE staining combined with Spencer colitis histological score were used to evaluate the degree of intestinal inflammation and histological changes in the two groups. ELISA was used to detect the levels of interleukin-1β (IL-1β), tumor necrosis factor alpha(TNF-α) and IL-10 in the intestinal mucosa, the levels of IL-6 and monocyte chemoattractant protein 1 (MCP-1) in the mesenteric adipose tissues. The mean diameter of adipocytes in the mesenteric adipose tissues was calculated under light microscope after HE staining.The number of F4/80+ macrophages and the expressions of peripherin, adiponectin and leptin in mesenteric adipose tissues were detected by immunohistochemical staining. The phosphorylation of NF-κBp65, IKK, IκB proteins in the mesenteric adipose tissues was detected by Western blot analysis. Results The DAI score of rosiglitazone group was significantly lower than that of model group at 5 and 6 weeks after rosiglitazone treatment. At the same time, the levels of IL-1β and TNF-α in the intestinal mucosa of the treated group were significantly lower than those in the model group, while the IL-10 levels were significantly higher in the treated group than in the model group. Compared with the model group, the mesenteric adipocyte diameter and the perilipin level of adipocyte maturation markers in rosiglitazone treated mice were significantly higher than those in model group. Meanwhile, the number of infiltration of macrophages in mesenteric adipose tissues of mice treated with rosiglitazone and the levels of inflammatory mediators IL-6 and MCP-1 were significantly lower than that of the model group. Rosiglitazone significantly promoted the expression of adiponectin and inhibited the expression of leptin in mesenteric adipocytes. The phosphorylation of NF-κBp65, IKK and IκB proteins in mesenteric adipose tissues of rosiglitazone treated mice was significantly lower than those of model group. Conclusion Rosiglitazone significantly inhibites intestinal inflammation in TNBS-induced colitis in mice, which may be related to the inhibition of NF-κBp65 pathway in mesenteric adipose tissues.

Rosiglitazone alleviates LPS-induced endometritis via suppression of TLR4-mediated NF-κB activation

Effects of Rosiglitazone on Serum Levels of Lipids and Inflammatory Factors in Atherosclerotic Rats

Engeletin Alleviates Lipopolysaccharide-Induced Endometritis in Mice by Inhibiting TLR4-mediated NF-κB Activation.

Inhibitory Effects of Rosiglitazone on Lipopolysaccharide-Induced Inflammation in a Murine Model and HK-2 Cells

Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis

Anti-inflammatory Effects of Rosmarinic Acid in Lipopolysaccharide-Induced Mastitis in Mice

[Rosiglitazone Ameliorates TNBS-induced Colitis in Mice by Inhibiting Inflammation of the Mesenteric Adipose Tissues].

PPARγ Agonist Rosiglitazone Ameliorates LPS-induced Inflammation in Vascular Smooth Muscle Cells Via the TLR4/TRIF/IRF3/IP-10 Signaling Pathway

Influence of Rosiglitazone on pulmonary inflammation induced by endotoxin in rats

Thymol Mitigates Lipopolysaccharide-Induced Endometritis by Regulating the TLR4- and ROS-mediated NF-κB Signaling Pathways

Ginsenoside Rg1 Alleviates Lipopolysaccharide-Induced Fibrosis of Endometrial Epithelial Cells in Dairy Cows by Inhibiting Reactive Oxygen Species-Activated NLRP3

Ginsenoside Rb1 Mitigates Escherichia coli Lipopolysaccharide-Induced Endometritis through TLR4-Mediated NF-κB Pathway

Glycyrrhizin Inhibits Lipopolysaccharide-Induced Inflammatory Response by Reducing TLR4 Recruitment into Lipid Rafts in RAW264.7 Cells.

Effect of rosiglitazone on the secretion of chemokines in renal tubular epithelial cells stimulated by lipopolysaccharide and the possible mechanism

Platelet rich plasma alleviates endometritis induced by lipopolysaccharide in mice via inhibiting TLR4/NF-κB signaling pathway

Enhanced anti-inflammatory effect of Rosmarinic acid by encapsulation and combination with the exosome in mice with LPS-induced endometritis through suppressing the TLR4-NLRP3 signaling pathway

Epigallocatechin‐3‐gallate (EGCG) attenuates inflammatory responses and oxidative stress in lipopolysaccharide (LPS)‐induced endometritis via silent information regulator transcript‐1 (SIRT1)/nucleotide oligomerization domain (NOD)‐like receptor pyrin domain‐containing 3 (NLRP3) pathway

MicroRNA Let-7C Improves LPS-Induced Outcomes of Endometritis by Suppressing NF-κB Signaling

Fisetin Ameliorates the Inflammation and Oxidative Stress in Lipopolysaccharide-Induced Endometritis

[Inhibitory Effects of Rosiglitazone on Angiotensin II-induced Toll-Like Receptor 4 Expression and Myeloperoxidase Activity in RAW264.7 Cells].

Regulation of rosiglitazone on MUC5AC expression induced by endotoxin in rat airway epithelium